The Journal of Immunology, Vol 145, Issue 1 117-126, Copyright © 1990 by American Association of Immunologists

ARTICLES

Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction

MK Kennedy, LJ Tan, MC Dal Canto and SD Miller
Department of Microbiology-Immunology, Northwestern University Medical School, Chicago, IL 60611.

Intravenous administration of neuroantigen-coupled syngeneic splenocytes is an efficient regimen for Ag-specific regulation of relapsing experimental autoimmune encephalomyelitis (R-EAE) at the effector level of the disease process. Treatment of SJL/J mice with splenocytes coupled with mouse spinal cord homogenate (MSCH) or myelin proteolipid protein after immunization with mouse spinal cord homogenate in CFA, but before the onset of clinical signs specifically inhibited the expression of neuroantigen-specific delayed-type hypersensitivity responses and significantly suppressed the onset, severity, and the duration of clinical and histologic signs of R-EAE. In contrast, the clinical course of R-EAE was not affected by tolerization with myelin basic protein-coupled splenocytes, indicating that proteolipid protein-specific responses play the major role in active MSCH-induced R-EAE. To ensure a physical and temporal separation between the inductive and effector stages of the disease process, we also examined the effects of neuroantigen-coupled splenocytes on adoptive R-EAE. Treatment of recipient mice with MSCH-coupled splenocytes up to 6 days after the transfer of MBP-primed lymph node cells induced a dose-dependent, profound, and long-lasting inhibition of clinical and histologic signs of adoptive R-EAE. The demonstration that splenocytes coupled with a heterogeneous mixture of neuroantigens (i.e., MSCH) can inhibit established immune responses suggests that this methodology has potential for regulating ongoing immune responses associated with autoimmune disorders or chronic graft rejection in which the specific (auto)Ag has yet to be identified.

This article has been cited by other articles:

				H. Zhang, J. R. Podojil, X. Luo, and S. D. Miller Intrinsic and Induced Regulation of the Age-Associated Onset of Spontaneous Experimental Autoimmune Encephalomyelitis J. Immunol., October 1, 2008; 181(7): 4638 - 4647. [Abstract] [Full Text] [PDF]

				M. T. Getts, B. S. Kim, and S. D. Miller Differential Outcome of Tolerance Induction in Naive versus Activated Theiler's Virus Epitope-Specific CD8+ Cytotoxic T Cells J. Virol., June 15, 2007; 81(12): 6584 - 6593. [Abstract] [Full Text] [PDF]

				D. M. Turley and S. D. Miller Peripheral Tolerance Induction Using Ethylenecarbodiimide-Fixed APCs Uses both Direct and Indirect Mechanisms of Antigen Presentation for Prevention of Experimental Autoimmune Encephalomyelitis J. Immunol., February 15, 2007; 178(4): 2212 - 2220. [Abstract] [Full Text] [PDF]

				T. N. Eagar, D. M. Turley, J. Padilla, N. J. Karandikar, L. Tan, J. A. Bluestone, and S. D. Miller CTLA-4 Regulates Expansion and Differentiation of Th1 Cells Following Induction of Peripheral T Cell Tolerance J. Immunol., June 15, 2004; 172(12): 7442 - 7450. [Abstract] [Full Text] [PDF]